GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 101 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,323 | -11.8% | 4,839 | 0.0% | 0.00% | – |
| Q2 2023 | $9,436 | -93.0% | 4,839 | -53.5% | 0.00% | -100.0% |
| Q4 2021 | $133,924 | +19.1% | 10,414 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $112,471 | +15.7% | 10,414 | -2.2% | 0.00% | +100.0% |
| Q2 2021 | $97,225 | +34.3% | 10,649 | +38.7% | 0.00% | 0.0% |
| Q1 2021 | $72,394 | +5.8% | 7,677 | -25.5% | 0.00% | 0.0% |
| Q2 2020 | $68,432 | +27.3% | 10,306 | +11.6% | 0.00% | 0.0% |
| Q1 2020 | $53,736 | -36.0% | 9,233 | -5.1% | 0.00% | 0.0% |
| Q3 2019 | $84,019 | +255.4% | 9,730 | +358.5% | 0.00% | – |
| Q2 2019 | $23,639 | – | 2,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |